Canada Life’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,336
| Closed | -$107K | – | 2406 |
|
|
2022
Q2 | $107K | Buy |
3,336
+659
| +25% | +$21.1K | ﹤0.01% | 1910 |
|
|
2022
Q1 | $99K | Sell |
2,677
-594
| -18% | -$22K | ﹤0.01% | 2002 |
|
|
2021
Q4 | $95K | Hold |
3,271
| – | – | ﹤0.01% | 2022 |
|
|
2021
Q3 | $84K | Hold |
3,271
| – | – | ﹤0.01% | 2096 |
|
|
2021
Q2 | $114K | Hold |
3,271
| – | – | ﹤0.01% | 2055 |
|
|
2021
Q1 | $132K | Sell |
3,271
-816
| -20% | -$32.9K | ﹤0.01% | 2040 |
|
|
2020
Q4 | $177K | Hold |
4,087
| – | – | ﹤0.01% | 1995 |
|
|
2020
Q3 | $225K | Hold |
4,087
| – | – | ﹤0.01% | 1876 |
|
|
2020
Q2 | $257K | Hold |
4,087
| – | – | ﹤0.01% | 1847 |
|
|
2020
Q1 | $209K | Hold |
4,087
| – | – | ﹤0.01% | 1801 |
|
|
2019
Q4 | $323K | Buy |
+4,087
| New | +$323K | ﹤0.01% | 1820 |
|
|
2019
Q3 | – | Sell |
-7,451
| Closed | -$391K | – | 2502 |
|
|
2019
Q2 | $391K | Buy |
7,451
+688
| +10% | +$36.1K | ﹤0.01% | 1852 |
|
|
2019
Q1 | $357K | Hold |
6,763
| – | – | ﹤0.01% | 1729 |
|
|
2018
Q4 | $268K | Buy |
6,763
+1,794
| +36% | +$71.1K | ﹤0.01% | 1854 |
|
|
2018
Q3 | $189K | Hold |
4,969
| – | – | ﹤0.01% | 1994 |
|
|
2018
Q2 | $224K | Buy |
4,969
+1,469
| +42% | +$66.2K | ﹤0.01% | 1944 |
|
|
2018
Q1 | $169K | Hold |
3,500
| – | – | ﹤0.01% | 2010 |
|
|
2017
Q4 | $137K | Hold |
3,500
| – | – | ﹤0.01% | 2071 |
|
|
2017
Q3 | $103K | Hold |
3,500
| – | – | ﹤0.01% | 2144 |
|
|
2017
Q2 | $96K | Hold |
3,500
| – | – | ﹤0.01% | 2136 |
|
|
2017
Q1 | $129K | Buy |
+3,500
| New | +$129K | ﹤0.01% | 2030 |
|